Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 906 participants.
Also called NCT06571149
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 906 participants
- Registry
-
NCT06571149
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, Canada, Finland, France, Germany, Greece, Netherlands, Norway, Portugal, Spain, Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT06571149. Randomized; no masking; primary purpose treatment. Start 2025-03-14 (actual); primary completion 2029-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
- Acronym
- DO-IT
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Tenecteplase or Alteplase
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
Record details
- Record id
cardio:ct-nct06571149- Content hash
b999bfc8fc380488aab4b0092ff9f2a68e08c4eb64ce8d2c7aa985d316fcbd72